SCHEMBL21134014

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL7901685	0.79	TSHR (0.37)	TSHR
	SCHEMBL15153583	0.78	GPR84 (0.48)	LMNATSHRBLMNFKB1
	SCHEMBL3501372	0.78	GPR84 (0.48)	LMNATSHRBLMNFKB1
	SCHEMBL11363078	0.78	GPR84 (0.48)	LMNATSHRBLMNFKB1
	SCHEMBL4977789	0.78	GPR84 (0.48)	LMNATSHRBLMNFKB1
	SCHEMBL8402045	0.78	GPR84 (0.48)	LMNATSHRBLMNFKB1
	SCHEMBL2818859	0.78	GPR84 (0.48)	LMNATSHRBLMNFKB1
	SCHEMBL2818864	0.78	GPR84 (0.48)	LMNATSHRBLMNFKB1
	SCHEMBL154286	0.78	DNM1 (0.50)	CA12CA1CA2CA3CA4
	SCHEMBL9812329	0.78	DNM1 (0.50)	CA12CA1CA2CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.